Status:
COMPLETED
Three Inflation Methods of the Ambú Auraonce™ and Its Adverse Effects
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Conditions:
Laryngeal Mask Airway
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Laryngeal mask airway device (LMA) is a common device used in the daily practice for airway management. Consecutive generations have permitted an expansion of its use, probably because of a rapid incr...
Detailed Description
This is a prospective randomized controlled trial. The study was approved by the Ethics Committee of University Hospital of La Paz, Madrid. Written informed consent will be obtained from each patient ...
Eligibility Criteria
Inclusion
- Patients age between 18 and 90 years
- American Society of Anesthesiologists (ASA) physical status I-III
- fiberoptic bronchoscopy procedure and EBUS-TBNA procedure programmed.
- Fasted for 6 hours before procedure.
- Management of the airway for the same anesthetic.
- Use de laryngeal mask airway for boarding and maintenance of airway permeability
Exclusion
- LMA is contraindicated because high risk of aspiration (full stomach, gastroesophageal reflux history, pregnant)
- predictors of difficult airway such restricted mouth opening (\< 3 cm of interincisal distance)
- patients with any pathology of the neck, upper respiratory or upper alimentary tract
- BMI \> 40 Kilogram / m2
- dysphagia o hoarseness
Key Trial Info
Start Date :
July 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 21 2018
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04769791
Start Date
July 17 2017
End Date
November 21 2018
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teresa Prim Martinez
Madrid, Spain, 28034